• Latest Posts

GSK partners to Scale Manufacturing of CAR-T Therapies

This Bone Cell Therapy Could Make it to a Shelf Near You

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?

Could this new TCR Lung Cancer Trial Save Adaptimmune from a Volatile Stock Situation?

“The Next Generation of Biologicals will be Cell-based”

ADVERTISEMENT

What happened this week? mRNA Therapies, TCR & Algae Beer

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin

Louvain-la-Neuve: A Belgian temple for success in cell therapy

Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors

ADVERTISEMENT